• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

FDA-Approved and Pipeline Treatments for Elevated Lp(a) Levels

Opinion
Video

Experts discuss FDA-approved therapies for high lipoprotein(a) [Lp[a]) levels, their benefits and shortcomings, the frequency of their use in health plans, emerging therapies in the pipeline, and the expected timeline for associated data release.

Video content above is prompted by the following:

  • What therapies for high Lp(a) levels are currently approved by the FDA?
  • What benefits and shortcomings (eg, cost, time) are associated with this therapy?
  • How frequently is this therapy used in the health plans you work with?
  • What therapies are in the pipeline?
  • When do we expect associated data to be released?
Related Videos
Varsha Tanguturi, MD, MPH, Mass General Hospital
 Khush Kharidia, MD, UT Southwestern
Alexandra M. Trevino, MD, Northwestern Medicine
2 experts in this video
2 experts in this video
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.